Short communication · 4 Aug 2026
Conference abstractPublished 16 Oct 2017
Low-density lipoproteins and triglyceride removal by plasma perfusion with active charcoal at atherosclerosis and cholestatic liver disease
Republican Specialized Center of Surgery, Uzbekistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: The development of artificial organs support system remains an important issue due to a high mortality rate of multi-organ dysfunction. Atherosclerosis and chronic cholestatic liver disease is common associated with hyperlipidemia, increase of low-density lipoprotein (LDL) cholesterol level. Active charcoal (AC), a highly porous material, has been widely used for endotoxins reducing through hemoperfusion. Plasma perfusion has several advantages: less loss of blood components, less activation of the coagulation system, safety. The purpose of this study is to evaluate adsorption capacity of AC for total bilirubin (TBil), total cholesterol (TC), LDL, triglyceride (TG) and its removal. Methodology & Theoretical Orientation: Static adsorption experiments in vitro was made using AC with median diameter 0.3Ã?¢Ã?Â?Ã?Â?0.6 mm; the inner porous surface ranged between 1200Ã?¢Ã?Â?Ã?Â?1300 mÃ?Â?Ã?²/g. 350 mg AC have been washed with 5 ml normal saline and then 1.0 ml of human plasma was added to AC in lab tube with diameter 1.5 cm. Adsorption lasted 30 min. Concentration of TC, LDL, TG, TBil were made before and after adsorption with AC on the automatic analyzer Ã?Â?Ã?«VITROS-350Ã?Â?Ã?» (USA). Statistical analysis was performed using Excel Microsoft for t-pair test. Significance was at the P<0.05 level. Findings: The results of the experiment in vitro demonstrate high adsorption capacity of AC during static plasma adsorption. After plasma adsorption TBil decreased on 42.3%, TC Ã?¢Ã?Â?Ã?Â? on 25.8%, LDL Ã?¢Ã?Â?Ã?Â? on 22.48%, urea Ã?¢Ã?Â?Ã?Â? on 49.7%%, creatinine Ã?¢Ã?Â?Ã?Â? on 71.6% (p<0.01). Conclusion & Significance: Plasma perfusion using AC may be used for the treatment of cholestatic liver failure disease and decrease a risk of cardiovascular disease among these patients.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Zarina R Khaybullina”
- BylineArticles whose byline prints “Rustam A Sadykov”
- BylineArticles whose byline prints “Olga V Kim”
- BylineArticles whose byline prints “Lusia M Akhmedjanova”
